From: Role of STREM-1 for early prediction of ventilator-associated pneumonia in pediatrics
Parameters | Non-VAP (n = 28) | VAP (n = 28) | Test | P-value | |
---|---|---|---|---|---|
Age (months) | 29.14 ± 5.51 | 30.07 ± 7.37 | − 0.211 | 0.834 | |
Sex | Female | 9 (32.1%) | 8 (28.6%) | 0.084 | 0.771 |
Male | 19 (67.9%) | 20 (71.4%) | |||
Underlying diseases | |||||
Septic shock (n, 23/56) | 11 (39.3%) | 12 (42.9%) | 0.074 | 0.786 | |
CNS infection(n, 20/56) | 10 (35.7%) | 10 (35.7%) | 0.000 | 1.000 | |
Cardiac patients(n, 7/56) | 4 (14.3%) | 3 (10.7%) | 0.163 | 0.687 | |
Postoperative(n, 6/56) | 3 (10.7%) | 3 (10.7%) | 0.000 | 1.000 | |
Laboratory tests | |||||
Hb | 11.36 ± 1.73 | 11.64 ± 1.57 | 0.420 | 0.520 | |
WBCs | 8.39 ± 2.36 | 10.01 ± 2.94 | − 2.276 | 0.027 | |
Platelets | 337.57 ± 58.33 | 364.68 ± 63.88 | 1.175 | 0.103 | |
Sputum culture + ve | 7 (25.0%) | 12 (42.9%) | 1.991 | 0.158 | |
Blood culture + ve | 10 (35.7%) | 12 (42.9%) | 0.299 | 0.584 |